comparemela.com

Latest Breaking News On - Rifaat safadi - Page 1 : comparemela.com

Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare.

Chemomab Reports Top-Line Results from CM-101 Phase 2a Liver Fibrosis Biomarker Trial in NASH Patients

—CM-101 Met Primary Endpoint of Safety and Tolerability and Showed Positive Activity Across Multiple Liver Fibrosis Biomarkers and Physiologic Assessments— TEL AVIV, Israel, Jan. 3, 2023. | January 3, 2023

Researchers discover rare form of liver cancer in Mice

The cell of origin of mixed liver/biliary duct carcinomas, a rare type of liver cancer, has been found in mice by researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Hebrew University in Jerusalem

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.